DENTSPLY SIRONA Inc. Files 8-K on Officer/Director Changes

Ticker: XRAY · Form: 8-K · Filed: 2025-05-29T00:00:00.000Z

Sentiment: neutral

Topics: leadership-change, officer-appointment, director-election, compensation

Related Tickers: DSNY

TL;DR

DSNY filed an 8-K detailing leadership changes and executive compensation arrangements.

AI Summary

DENTSPLY SIRONA Inc. filed an 8-K on May 29, 2025, reporting events as of May 27, 2025. The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes Regulation FD disclosures and financial statements/exhibits.

Why It Matters

This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.

Risk Assessment

Risk Level: medium — Changes in directors or officers can signal underlying issues or strategic shifts that may affect the company's future performance.

Key Players & Entities

FAQ

What specific officer or director positions were affected by the events reported on May 27, 2025?

The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" but does not specify the names or exact roles in the provided text.

Are there any details regarding the compensatory arrangements for the officers mentioned?

The filing lists "Compensatory Arrangements of Certain Officers" as an item of information, but the specific details of these arrangements are not included in the provided text.

What is the significance of the Regulation FD Disclosure mentioned in the filing?

Regulation FD disclosures ensure that material non-public information is broadly disseminated to the public, preventing selective disclosure to analysts or institutional investors.

Does the 8-K filing include updated financial statements?

Yes, the filing explicitly states "Financial Statements and Exhibits" as an item of information, suggesting that financial information or related exhibits are included.

What is the company's primary business sector based on its SIC code?

DENTSPLY SIRONA Inc. is classified under "DENTAL EQUIPMENT & SUPPLIES" with SIC code 3843.

From the Filing

0000818479-25-000086.txt : 20250529 0000818479-25-000086.hdr.sgml : 20250529 20250529164238 ACCESSION NUMBER: 0000818479-25-000086 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20250527 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250529 DATE AS OF CHANGE: 20250529 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DENTSPLY SIRONA Inc. CENTRAL INDEX KEY: 0000818479 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 391434669 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-16211 FILM NUMBER: 251004161 BUSINESS ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 BUSINESS PHONE: 844-546-3722 MAIL ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 FORMER COMPANY: FORMER CONFORMED NAME: DENTSPLY INTERNATIONAL INC /DE/ DATE OF NAME CHANGE: 19930630 FORMER COMPANY: FORMER CONFORMED NAME: GENDEX CORP DATE OF NAME CHANGE: 19920703 8-K 1 xray-20250527.htm 8-K xray-20250527 0000818479 false 0000818479 2025-05-27 2025-05-27 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 27, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North Carolina 28277-3607 (Address of Principal Executive Offices) (Zip Code) ( 844) 848-0137 (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On May 27, 2025, the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) appointed Matthew E. Garth as the Company’s Executive Vice President & Chief Financial Officer, effective as of May 30, 2025 (the “Effective Date”). Mr. Garth, age 51, most recently served as the Executive Vice President, Chief Financial Officer & Chief Admini

View on Read The Filing